Medicenna Therapeutics Corp.
MDNAF$25M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaTORONTO18 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
This month
Market Overview
Stock performance and key metrics
MDNAF News
Catalyst Timeline
1 upcoming, 0 past
Phase 2Next
MDNA11 Phase 2 Est. Readout
June 2026~ConfirmedMDNA11115
Primary completion for MDNA11 trial (NCT05086692) in Advanced Solid Tumor
SourceDrug Pipeline
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply